Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Asset Utilization Ratio (2016 - 2025)

Abeona Therapeutics has reported Asset Utilization Ratio over the past 15 years, most recently at 0.03 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.03 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 0.03 (changed N/A YoY), and the annual figure for FY2025 was 0.04, changed.
  • Asset Utilization Ratio for Q4 2025 was 0.03 at Abeona Therapeutics, up from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for ABEO hit a ceiling of 0.07 in Q2 2023 and a floor of 0.04 in Q4 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.03 (2022), compared with a mean of 0.02.
  • Peak annual rise in Asset Utilization Ratio hit 1508.09% in 2021, while the deepest fall reached 166.26% in 2021.
  • Abeona Therapeutics' Asset Utilization Ratio stood at 0.04 in 2021, then surged by 174.84% to 0.03 in 2022, then skyrocketed by 95.93% to 0.05 in 2023, then fell by 6.3% to 0.05 in 2024, then crashed by 48.77% to 0.03 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.03 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025) per Business Quant data.